| Evaluation of the efficacy and safety of switching to pasireotide in patients with acromegaly inadequately controlled with first-generation somatostatin analogs M Gadelha, M Bex, A Colao, EM Pedroza García, C Poiana, ... Frontiers in Endocrinology 10, 931, 2020 | 28 | 2020 |
| Efficacy and safety of patiromer in hyperkalemia: a systematic review and meta-analysis S Das, JK Dey, S Sen, R Mukherjee Journal of Pharmacy Practice 31 (1), 6-17, 2018 | 22 | 2018 |
| Pre‐transplant cognitive screening is a poor predictor of post‐transplant cognitive status A Gupta, RN Montgomery, K Young, R Mukherjee, S Chakraborty, ... Clinical transplantation 36 (11), e14798, 2022 | 7 | 2022 |
| Effect of Tacrolimus Levels on Cerebral Blood Flow and Cognitive Function: A Pilot Study H Tariq, K Young, RN Montgomery, R Mukherjee, RJ Lepping, ... Kidney360, 10.34067, 2024 | 1 | 2024 |
| The Association of tacrolimus formulation on cerebral blood flow and cognitive function I Mahaparn, RJ Lepping, RN Montgomery, R Mukherjee, SA Billinger, ... Transplantation Direct 9 (8), e1511, 2023 | 1 | 2023 |
| Elucidating the influences of social determinants of health on perceived overall health among African American/Black and Hispanic ovarian cancer survivors using the NIH All of … DE Mahoney, R Mukherjee, J Thompson Gynecologic Oncology 189, 24-29, 2024 | | 2024 |
| Impact of Changing Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function. I Mahaparn, R Lepping, RN Montgomery, R Mukherjee, S Billinger, ... AMERICAN JOURNAL OF TRANSPLANTATION 22, 905-905, 2022 | | 2022 |
| Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues … M Gadelha, A Colao, M Bex, R Mukherjee, C Bourad, R Maamari, ... Endocrine Abstracts 63, 2019 | | 2019 |
